Radioimmunotherapy with Tenarad, a 131I-labelled antibody fragment targeting the extra-domain A1 of tenascin-C, in patients with refractory Hodgkin's lymphoma
Publication status
publishedExternal links
Journal / series
European Journal of Nuclear Medicine and Molecular ImagingVolume
Pages / Article No.
Publisher
SpringerSubject
Dosimetry; Hodgkin's lymphoma; Radioimmunotherapy; Tenascin-COrganisational unit
03463 - Neri, Dario (ehemalig) / Neri, Dario (former)
Notes
Received 6 September 2013, Accepted 28 November 2013, Published online 17 January 2014.More
Show all metadata